--------------------------------------------------------------------------------

Testoderm TTS CIII

The following drug information is obtained from various newswires, published medical journal articles, and medical conference presentations.

Company:

Approval Status:

Approved December 1997

Specific Treatments:

testosterone deficiency

Therapeutic Areas

General Information

Testoderm TTS CIII has been approved for men with testosterone deficiency. It is a transdermal patch that delivers a 5-mg dose of testosterone during a 24-hour period.

Clinical Results

Clinical Results: Clinical trials showed that application of the Testoderm patch maintained normal serum testosterone levels, with delivery comparable to the normal circadian pattern of testosterone secretion.

---------------------------------------------------------------------------------

[ Home | Discussions | Article Archives | Help | Submit your Site]

Copyright 1996 - 2014 by Gelber Associates All Rights Reserved.